OncoEthix Raises $19 Mln
OncoEthix has closed a Series B financing raising 18 Million CHF (~US$19 Million) led by SV Life Sciences. Edmond de Rothschild Investment Partners, a new investor, also participated along with Index Ventures and Endeavour Vision. OncoEthix, of Switzerland, is a specialist in oncology drug development.
8 July 2013•4 mins read
